Showing results (491-500 of 640) with videos related to

Sort By:
Pageof 64
Current Medical Research and Opinion|March 16, 2010
Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL studyD Fliser, W Kleophas, F Dellanna, et al.
Clinical Nephrology|December 24, 1997
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppressionE Allmaras, R Nowack, K Andrassy, et al.
Glycoconjugate Journal|October 1, 1995
L-fucose residues on cellulose-based dialysis membranes: quantification of membrane-associated L-fucose and analysis of specific lectin bindingC Meissner, R Deppisch, F Hug, et al.
Clinical Nephrology|October 30, 2009
Optimal blood pressure control versus additional immunosuppressive therapy in idiopathic membranous nephropathy - a retrospective analysisR Dikow, P Quentmeier, V Schwenger, et al.
Kidney International|February 1, 1990
Fluid phase generation of terminal complement complex as a novel index of bioincompatibilityR Deppisch, V Schmitt, J Bommer, et al.
Blood Purification|January 1, 1985
Response of alkaline phosphatase to zinc repletion in hypozincemic hemodialysis patientsG Stammler, P Klooker, J Bommer, et al.
Clinical Nephrology|November 5, 2004
Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein bindingJ T Kielstein, R H Böger, S M Bode-Böger, et al.
Nephron|January 1, 1990
Growth hormone induced rise in glomerular filtration rate is not obliterated by angiotensin-converting enzyme inhibitorsD Haffner, E Ritz, O Mehls, et al.
Deutsche Medizinische Wochenschrift (1946)|January 3, 2004
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]A J Palmer, L Annemans, S Roze, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failureK Amann, C Nichols, J Tornig, et al.
Pageof 64